Navidea Biopharmaceuticals Inc (NAVB)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Navidea Biopharmaceuticals Inc (NAVB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011047
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Navidea Biopharmaceuticals Inc (Navidea) is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key product, Lymphoseek (technetium Tc 99m tilmanocept) injection, is a radiopharmaceutical agent used in intra-operative lymphatic mapping (ILM), external lymph node imaging (lymphoscintigraphy) and sentinel lymph node biopsy. The company’s products in pipeline includes lifecycle management of Lymphoseek; and NAV4694, a fluorine-18 PET (positron emission tomography) imaging agent, is being developed for the diagnosis of cognitive impairment and dementia, including Alzhemier’s disease. Navidea by utilizing its Manocept platform develops multiple precision-targeted products to identify pathways of undetected disease and provide better diagnostic accuracy, clinical decision-making and effective treatment. The company has presence in the US, Israel and the UK. Navidea is headquartered in Dublin, Ohio, the US.

Navidea Biopharmaceuticals Inc (NAVB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Navidea Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Navidea Biopharmaceuticals Inc, Medical Equipment, Deal Details 10
Partnerships 10
Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma 10
Naviscan PET Systems Enters Into Licensing Agreement With Neoprobe 11
Cerveau to Enter into Licensing Agreement with Navidea Biopharma 12
Equity Offering 13
Navidea Biopharma Plans to Raise up to USD100 in Public Offering of Shares 13
Navidea Biopharma Completes Private Placement Of Units For US$30 Million 14
Navidea Biopharma Completes Public Offering Of Common Stock For US$5 Million 16
Navidea Biopharma Completes Private Placement Of Shares For US$5 Million 17
Navidea Biopharma Completes Private Placement Of Shares For US$2 Million Upon Exercise Of Warrants 19
Debt Offering 20
Neoprobe Completes Private Placement Of Convertible Secured Note For US$7 Million 20
Asset Transactions 21
Neoprobe Completes Sale Of Gamma Detection Device Business To Devicor Medical Products 21
Navidea Biopharmaceuticals Inc – Key Competitors 23
Navidea Biopharmaceuticals Inc – Key Employees 24
Navidea Biopharmaceuticals Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Recent Developments 26
Financial Announcements 26
Nov 08, 2017: Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results 26
May 09, 2017: Navidea Biopharmaceuticals Reports First Quarter 2017 Financial Results 28
Mar 29, 2017: Navidea Provides Corporate Update and Reports Full Year 2016 Results 30
Nov 03, 2016: Navidea Reports 2016 Third Quarter Financial Results 33
Aug 04, 2016: Navidea Reports Second Quarter 2016 Financial Results 35
May 17, 2016: Navidea Reports First Quarter 2016 Financial Results 38
Mar 23, 2016: Navidea Announces Fourth Quarter and Full Year 2015 Results 40
Corporate Communications 42
Sep 26, 2016: Navidea Appoints Michael M. Goldberg, M.D. President and Chief Executive Officer 42
Apr 26, 2016: Navidea Appoints Jed Latkin as Interim Chief Operating Officer 43
Product News 44
Nov 01, 2017: Navidea to Present Late-Breaking Abstract at American College of Rheumatology Annual Meeting 44
Apr 25, 2017: Navidea Biopharmaceuticals Invited to Present Data at Two Major Upcoming Conferences 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Navidea Biopharmaceuticals Inc, Medical Equipment, Key Facts, 2016 2
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Navidea Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Navidea Biopharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma 10
Naviscan PET Systems Enters Into Licensing Agreement With Neoprobe 11
Cerveau to Enter into Licensing Agreement with Navidea Biopharma 12
Navidea Biopharma Plans to Raise up to USD100 in Public Offering of Shares 13
Navidea Biopharma Completes Private Placement Of Units For US$30 Million 14
Navidea Biopharma Completes Public Offering Of Common Stock For US$5 Million 16
Navidea Biopharma Completes Private Placement Of Shares For US$5 Million 17
Navidea Biopharma Completes Private Placement Of Shares For US$2 Million Upon Exercise Of Warrants 19
Neoprobe Completes Private Placement Of Convertible Secured Note For US$7 Million 20
Neoprobe Completes Sale Of Gamma Detection Device Business To Devicor Medical Products 21
Navidea Biopharmaceuticals Inc, Key Competitors 23
Navidea Biopharmaceuticals Inc, Key Employees 24
Navidea Biopharmaceuticals Inc, Subsidiaries 25
Navidea Biopharmaceuticals Inc, Joint Venture 25

★海外企業調査レポート[Navidea Biopharmaceuticals Inc (NAVB)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • eHealth Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary eHealth Technologies Inc (eHealth), formerly eHealth Global Technologies Inc, is a healthcare technology company that provides clinical records and imaging services. The company provides eHealth connect platform which offers health systems with access to an intelligently organized clinical r …
  • Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析
    Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Petrofac Ltd (PFC):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrofac Limited (Petrofac) is an oilfield services company that provides integrated services to production and processing industries. It designs and builds oil and gas facilities; operates, maintains and manages facilities on behalf of its customers and trains personnel. It also develops an …
  • Cynvenio Biosystems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cynvenio Biosystems Inc (Cynvenio) is a cancer diagnostic company that focuses on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood. The company offers products such as lab automation systems, isolation products and proprietary informat …
  • Merafe Resources Ltd
    Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sumitomo Mitsui Trust Holdings Inc
    Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Sime Darby Berhad:企業の戦略・SWOT・財務分析
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Jersey Oil and Gas Plc (JOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Jersey Oil and Gas Plc (Jersey Oil), formerly Trap Oil Group Plc is an upstream oil and gas exploration and production company. The company acquires, explores, develops and produces natural gas properties in the UK continental shelf. Its oil and gas properties include Homer Block, Cortina Bl …
  • Evofem Biosciences Inc (EVFM):製薬・医療:M&Aディール及び事業提携情報
    Summary Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes reproductive and contraceptive care products for women. The company’s lead product candidate includes Amphora, a non-hormonal vaginal contraceptive gel for the prevention …
  • Integracion Energetica Argentina SA:企業の戦略的SWOT分析
    Integracion Energetica Argentina SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • pSivida Corp (PSDV)-製薬・医療分野:企業M&A・提携分析
    Summary pSivida Corp (pSivida) is a specialty pharmaceutical company that offers development of miniaturized, sustained-release drug delivery products and technologies. The company’s products include iluvien, retisert and durasert. Its durasert is an injectable, miniaturized, sustained-release drug …
  • Tecan Group Ltd (TECN):製薬・医療:M&Aディール及び事業提携情報
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • THIMM Group GmbH + Co. KG:企業の戦略・SWOT・財務情報
    THIMM Group GmbH + Co. KG - Strategy, SWOT and Corporate Finance Report Summary THIMM Group GmbH + Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Carlsberg AS (CARL B):企業の財務・戦略的SWOT分析
    Carlsberg AS (CARL B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fisia Italimpianti SpA:企業の戦略的SWOT分析
    Fisia Italimpianti SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Wartsila Corp (WRT1V):電力:M&Aディール及び事業提携情報
    Summary Wartsila Corp (Wartsila) is a mechanical or industrial engineering company. It offers smart technologies and complete lifecycle solutions. Through sustainable innovation, total efficiency, and data analytics, the company harnesses the environmental and economic performance of the vessels and …
  • Neusoft Corporation (600718):企業の財務・戦略的SWOT分析
    Neusoft Corporation (600718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Laboratoires Pierre Fabre SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs …
  • Volkswagen AG (VOW3):企業の財務・戦略的SWOT分析
    Volkswagen AG (VOW3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆